502 related articles for article (PubMed ID: 26607343)
1. Procalcitonin to guide antibiotic therapy in the ICU.
Bréchot N; Hékimian G; Chastre J; Luyt CE
Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S19-24. PubMed ID: 26607343
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
3. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
[TBL] [Abstract][Full Text] [Related]
4. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
Kip MM; Kusters R; IJzerman MJ; Steuten LM
J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
[TBL] [Abstract][Full Text] [Related]
5. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.
Hohn A; Schroeder S; Gehrt A; Bernhardt K; Bein B; Wegscheider K; Hochreiter M
BMC Infect Dis; 2013 Apr; 13():158. PubMed ID: 23547790
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
8. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
Schuetz P; Raad I; Amin DN
Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
[TBL] [Abstract][Full Text] [Related]
11. Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections?
Pantelidou IM; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S10-2. PubMed ID: 26686272
[TBL] [Abstract][Full Text] [Related]
12. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.
Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schroeder S
Crit Care; 2009; 13(3):R83. PubMed ID: 19493352
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.
Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530
[TBL] [Abstract][Full Text] [Related]
15. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
[TBL] [Abstract][Full Text] [Related]
16. Use of procalcitonin for the prediction and treatment of acute bacterial infection in children.
Pierce R; Bigham MT; Giuliano JS
Curr Opin Pediatr; 2014 Jun; 26(3):292-8. PubMed ID: 24739491
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome.
Charles PE; Tinel C; Barbar S; Aho S; Prin S; Doise JM; Olsson NO; Blettery B; Quenot JP
Crit Care; 2009; 13(2):R38. PubMed ID: 19291325
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
[TBL] [Abstract][Full Text] [Related]
19. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in the critically ill patient: procalcitonin.
Reinhart K; Meisner M
Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
